Hopefully approved this year, also should require less patients? 6-12 months for the trail? All dependamt on enrollments, which could still be a problem
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling